Quince Therapeutics, Inc. (QNCX)
31.32
+0.77
(+2.52%)
USD |
NASDAQ |
Sep 04, 16:00
31.18
-0.14
(-0.43%)
After-Hours: 20:00
Quince Therapeutics Market Cap : 31.86M for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 31.86M |
| September 03, 2026 | 31.07M |
| September 02, 2026 | 32.70M |
| September 01, 2026 | 32.66M |
| August 31, 2026 | 33.13M |
| August 28, 2026 | 34.33M |
| August 27, 2026 | 33.06M |
| August 26, 2026 | 31.85M |
| August 25, 2026 | 31.46M |
| August 24, 2026 | 34.05M |
| August 21, 2026 | 34.51M |
| August 20, 2026 | 32.66M |
| August 19, 2026 | 35.16M |
| August 18, 2026 | 33.47M |
| August 17, 2026 | 34.70M |
| August 14, 2026 | 34.62M |
| August 13, 2026 | 32.96M |
| August 12, 2026 | 31.79M |
| August 11, 2026 | 33.29M |
| August 10, 2026 | 21.13M |
| August 07, 2026 | 20.82M |
| August 06, 2026 | 20.37M |
| August 05, 2026 | 19.91M |
| August 04, 2026 | 18.90M |
| August 03, 2026 | 17.21M |
| Date | Value |
|---|---|
| July 31, 2026 | 16.13M |
| July 30, 2026 | 15.88M |
| July 29, 2026 | 15.17M |
| July 28, 2026 | 13.36M |
| July 27, 2026 | 12.31M |
| July 24, 2026 | 12.31M |
| July 23, 2026 | 12.60M |
| July 22, 2026 | 12.78M |
| July 21, 2026 | 12.95M |
| July 20, 2026 | 12.98M |
| July 17, 2026 | 13.02M |
| July 16, 2026 | 12.87M |
| July 15, 2026 | 12.81M |
| July 14, 2026 | 13.30M |
| July 13, 2026 | 11.89M |
| July 10, 2026 | 12.09M |
| July 09, 2026 | 12.06M |
| July 08, 2026 | 11.89M |
| July 07, 2026 | 12.07M |
| July 06, 2026 | 11.71M |
| July 02, 2026 | 11.88M |
| July 01, 2026 | 11.55M |
| June 30, 2026 | 12.54M |
| June 29, 2026 | 12.70M |
| June 26, 2026 | 13.01M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 12.19B |
| Oncolytics Biotech, Inc. | 105.09M |
| Sangamo Therapeutics, Inc. | 66.70M |
| Sarepta Therapeutics, Inc. | 2.377B |
| Anixa Biosciences, Inc. | 104.14M |
Market Cap Related Metrics
| Price | 31.32 |
| Earnings Yield | -401.0% |